The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157 Peptide Therapy in Jacksonville Area: Healing and Recovery BlueWater Wellness & MedSpa FDA mulls compounding for peptides previously flagged over safety risks BioSpace In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives FDA takes first step in possible reversal of ban on some peptides The Washington Post